Praxis Genomics is first CLIA Lab to become a Bionano Certified Service Provider, will use Saphyr in its goal to help end diagnostic odyssey for patients. SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Praxis Genomics has been certified as a Bionano service provider, becoming the first clinical lab with CLIA certification […]
Vienna, Austria, August 19, 2020 – Today Lexogen, the transcriptomics and next-generation sequencing company, announced the launch of the QuantSeq-Pool Sample-Barcoded 3’ mRNA-Seq Library Prep Kit. The QuantSeq-Pool method combines sample barcoding and early pooling with the benefits of Lexogen’s established QuantSeq 3’ mRNA-Seq kit, which has been already cited in more than 550 publications. Hence, […]
CARLSBAD, Calif. — In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today, Thermo Fisher Scientific announces a new portfolio of hematology-oncology assays for the Ion Torrent Genexus System* designed to enable a future in which turnaround times for next-generation sequencing (NGS) […]
Bespoke custom contract service offers rapid access to broad range of high-quality antigen panels for influenza A and B viruses Oxford, UK: The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today […]
CELLINK AB (publ) (“CELLINK”) has entered into an agreement with the owners of Scienion Ag (“Scienion”), a German life science company focusing on precision dispensing technologies, to acquire all shares for a purchase price on cash- and debt-free basis of 80M euros (the “Acquisition”). 40M euros will be paid in 2,814,032 newly issued shares of series […]
As announced CELLINK AB (publ) (“CELLINK”) entered into an agreement to acquire the precision dispensing company Scienion AG. CELLINK has on this day completed the acquisition of all Scienion-shares. The purchase price, on cash- and debt-free basis, amounted to 80 MEUR, of which 40 MEUR was paid in 2,814,032 newly issued shares of series B […]
• QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing • QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research Hilden, Germany, and Germantown, Maryland – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with […]
Regarding the patent lawsuit initiated by Illumina against MGI in Hong Kong, the specific impact has yet to be determined. MGI believes that this patent litigation is an obvious attempt by Illumina to maintain a monopolistic market position and suppress the development of the industry. We intend to vigorously defend our intellectual property, and we have filed patent litigation against […]
The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical new vaccines and biologics SAN DIEGO — Today, Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput DNA printing, announced the introduction of their next-generation platform, the BioXp™ 3250 […]
Recombinant engineered antibodies available for coronavirus research and diagnostics Redcar, UK. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19. The antibodies, originally generated by Fred Hutchinson Cancer Research Center, have been engineered into recombinant formats useful for […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
